Cargando…

Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels

AIMS/INTRODUCTION: The renal threshold for glucose (RTg) corresponds to a blood glucose level of ~180 mg/dL; however, in hospitals, patients are often encountered who are hyperglycemic, but urine glucose test strip‐negative, who remain negative for urine glucose even at blood glucose concentrations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hieshima, Kunio, Sugiyama, Seigo, Yoshida, Akira, Kurinami, Noboru, Suzuki, Tomoko, Ijima, Hiroko, Miyamoto, Fumio, Kajiwara, Keizo, Jinnouchi, Katsunori, Jinnouchi, Tomio, Jinnouchi, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232275/ https://www.ncbi.nlm.nih.gov/pubmed/31770476 http://dx.doi.org/10.1111/jdi.13191

Ejemplares similares

The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Sugiyama, Seigo, et al.
Publicado: (2018)

Dapagliflozin Reduces Fat Mass without Affecting Muscle Mass in Type 2 Diabetes
por: Sugiyama, Seigo, et al.
Publicado: (2018)

Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center
por: Sugiyama, Seigo, et al.
Publicado: (2019)

Initial Acute Decline in Estimated Glomerular Filtration Rate After Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Chronic Kidney Disease
por: Sugiyama, Seigo, et al.
Publicado: (2020)

A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus
por: Sugiyama, Seigo, et al.
Publicado: (2015)

Smoking Cessation Ameliorates Microalbuminuria With Reduction of Blood Pressure and Pulse Rate in Patients With Already Diagnosed Diabetes Mellitus
por: Hieshima, Kunio, et al.
Publicado: (2018)

Body Muscle-to-Fat Ratio, Rather Than Fat-to-Muscle Ratio, Significantly Correlates With Measured Insulin Resistance in Patients With Type 2 Diabetes Mellitus
por: Kurinami, Noboru, et al.
Publicado: (2021)

Clinical Factors Associated with Initial Decrease in Body-Fat Percentage Induced by Add-on Sodium-Glucose Co-transporter 2 Inhibitors in Patient with Type 2 Diabetes Mellitus
por: Kurinami, Noboru, et al.
Publicado: (2017)

Impact of Dapagliflozin Therapy on Renal Protection and Kidney Morphology in Patients With Uncontrolled Type 2 Diabetes Mellitus
por: Sugiyama, Seigo, et al.
Publicado: (2018)

Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
por: Jinnouchi, Hideaki, et al.
Publicado: (2015)

Type 2 Diabetes Remission and Substantial Body Weight Reduction Achieved with Metformin and a Sodium-Glucose Cotransporter 2 Inhibitor
por: Sugiyama, Seigo, et al.
Publicado: (2020)

A Non-obese, Treatment-Naive Japanese Diabetic Patient With Elevated Insulin Clearance and Hyperglycemia Under Enhanced Insulin Sensitivity and Increased Insulin Secretion: Elevated Insulin Clearance as Type 2 Japanese Diabetes Mellitus (T2JDM)
por: Sugiyama, Seigo, et al.
Publicado: (2021)

Reduced Number of Remaining or Healthy Teeth in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study Assessed by Dentists or Dental Hygienists in Japan
por: Kurinami, Noboru, et al.
Publicado: (2023)

Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL(−1) and Glargine 100 U mL(−1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study
por: Jinnouchi, Hideaki, et al.
Publicado: (2015)

Predictive factors of durability to sitagliptin: Slower reduction of glycated hemoglobin, older age and higher baseline glycated hemoglobin
por: Chung, Hye Soo, et al.
Publicado: (2014)

The Authors Reply:
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2013)

An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2013)

Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
por: Toyama, Kensuke, et al.
Publicado: (2012)

Correction: Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
por: Toyama, Kensuke, et al.
Publicado: (2013)

Does Genetic Ancestry Explain Higher Values of Glycated Hemoglobin in African Americans?
por: Maruthur, Nisa M., et al.
Publicado: (2011)

Glycated Albumin versus Glycated Hemoglobin as a Glycemic Indicator in Diabetic Patients on Peritoneal Dialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2016)

Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis
por: Isoda, Hiroshi, et al.
Publicado: (2017)

Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis
por: Isoda, Hiroshi, et al.
Publicado: (2017)

Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes
por: Kajiwara, Ayami, et al.
Publicado: (2016)

Glycated albumin is correlated with glycated hemoglobin in type 2 diabetes
por: Ciobanu, Dana Mihaela, et al.
Publicado: (2019)

Albumin Abundance and Its Glycation Status Determine Hemoglobin Glycation
por: Jagadeeshaprasad, Mashanipalya G., et al.
Publicado: (2018)

Glycative Stress, Glycated Hemoglobin, and Atherogenic Dyslipidemia in Patients with Hyperlipidemia
por: Yao, Chien-An, et al.
Publicado: (2023)

False measurement of glycated hemoglobin in patients without hemoglobin A
por: Suo, Minghuan, et al.
Publicado: (2019)

Lower versus higher hemoglobin threshold for transfusion in ARDS patients with and without ECMO
por: Hunsicker, O., et al.
Publicado: (2020)

Effects of thyroid status on glycated hemoglobin
por: Bhattacharjee, Rana, et al.
Publicado: (2017)

The association of dyslipidemia and obesity with glycated hemoglobin
por: Sheth, Jayesh, et al.
Publicado: (2015)

Estimation of the hemoglobin glycation rate constant
por: Kameyama, Masashi, et al.
Publicado: (2021)

Higher values of fasting blood glucose and glycated hemoglobin are not associated with mortality in Covid-19 Mexican patients
por: Gastélum-Cano, José María, et al.
Publicado: (2021)

Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients
por: Lee, Minyoung, et al.
Publicado: (2019)

Serum glycated albumin, but not glycated hemoglobin, is low in relation to glycemia in men with hypertriglyceridemia
por: Koga, Masafumi, et al.
Publicado: (2010)

Evaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects
por: Liang, Libo, et al.
Publicado: (2018)

Redefining the Diagnosis of Diabetes Using Glycated Hemoglobin
por: Fonseca, Vivian, et al.
Publicado: (2009)

Prognostic value of glycated hemoglobin in colorectal cancer
por: Ferroni, Patrizia, et al.
Publicado: (2016)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Low-Dose Aspirin Therapy in Patients With Type 2 Diabetes and Reduced Glomerular Filtration Rate: Subanalysis from the JPAD trial
por: Saito, Yoshihiko, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ukl3uqgcdk6k16hd91aekaqnlv